title: Urogenital complaints and female sexual dysfunction. Part 2.
abstract: BACKGROUND
  Female sexual dysfunction (FSD) is common in women with urogenital disorders that occur as a result of pelvic floor muscle and fascial laxity.
  
  
  OBJECTIVE
  Provide a comprehensive review of FSD as it relates to common urogenital disorders including pelvic organ prolapse (POP) and stress urinary incontinence (SUI) and to discuss the impact of the surgical repair of these disorders on sexual function.
  
  
  METHODS
  Systematic search of the medical literature using a number of related terms including FSD, POP, SUI, surgical repair, graft augmentation, complications, and dyspareunia.
  
  
  METHODS
  Review of the medical literature to identify the relation between FSD and common urogenital disorders in women and to describe appropriate treatment strategies to improve quality of life (QOL) and sexual function.
  
  
  RESULTS
  FSD is common in women with POP and SUI. Treatment options for POP and SUI include behavioral, pharmacological, and surgical methods which can also affect sexual function.
  
  
  CONCLUSIONS
  Sexual dysfunction is a common, underestimated complaint in women with POP and SUI. Treatment should be tailored toward improving sexual function and QOL. Surgical correction is generally beneficial but occasionally can result in negative alterations in sexual function. Patient selection and methods used for surgical repair are important factors in determining anatomical and functional success.
authors.affiliation: Department of Obstetrics and Gynecology, Division of Female Pelvic Medicine and Reconstructive Surgery, Drexel University College of Medicine, Philadelphia, PA, USA. swehbe@drexelmed.edu
authors.forename: Salim A
authors.initials: SA
authors.lastname: Wehbe
authors.forename: Susan
authors.initials: S
authors.lastname: Kellogg
authors.forename: Kristene
authors.initials: K
authors.lastname: Whitmore
mesh_terms: D005260:Female; D006801:Humans; D008487:Medical History Taking; D012307:Risk Factors; D012737:Sex Factors; D012735:Sexual Dysfunction, Physiological / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology; D020018:Sexual Dysfunctions, Psychological / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology; D014481:United States / Q000453:epidemiology